Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 33,330 | 25,472 | 25,373 | 26,839 | 30,176 |
| Cost of Goods | 4,895 | 3,050 | 3,921 | 3,966 | 6,773 |
| Gross Profit | 28,435 | 22,422 | 21,452 | 22,873 | 23,403 |
| Operating Expenses | 21,346 | 16,538 | 34,374 | 16,332 | 57,272 |
| Operating Income | 7,984 | 5,934 | -12,001 | 7,507 | -33,096 |
| Interest Expense | 2,436 | 2,495 | 2,605 | 2,684 | 2,598 |
| Other Income | -507 | 344 | 137 | 269 | 346 |
| Pre-tax Income | 5,041 | 3,783 | -14,469 | 5,092 | -35,348 |
| Income Tax | 434 | 46 | -300 | 548 | -10,995 |
| Net Income Continuous | 4,607 | 3,737 | -14,169 | 4,544 | -24,353 |
| Net Income | $4,607 | $3,737 | $-14,169 | $4,544 | $-24,353 |
| EPS Basic Total Ops | 0.09 | 0.08 | -0.32 | 0.12 | -1.36 |
| EPS Basic Continuous Ops | 0.08 | 0.08 | -0.32 | 0.12 | -1.36 |
| EPS Diluted Total Ops | 0.09 | 0.08 | -0.32 | 0.12 | -1.36 |
| EPS Diluted Continuous Ops | 0.09 | 0.08 | -0.32 | 0.12 | -1.35 |
| EBITDA(a) | $15,398 | $13,387 | $-4,479 | $14,389 | $-26,067 |